Skip to search formSkip to main contentSkip to account menu

Oritavancin:Susc:Pt:Isolate:OrdQn:Gradient strip

Known as: Oritavancin [Susceptibility] by Gradient strip, Oritavancin Islt E-test, Oritavancin [Susceptibility] by Gradient strip (E-test) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
OBJECTIVE To assess critically oritavancin, a second-generation  lipoglycopeptide, for the treatment of Acute Bacterial Skin and… 
Review
2018
Review
2018
INTRODUCTION The resistance of gram-positive pathogens to currently available antibiotics has increased at an alarming rate… 
2018
2018
Oritavancin is a recently approved lipoglycopeptide with activity against Grampositive bacteria (1). For a number of reasons… 
Review
2017
Review
2017
Purpose of review The treatment of necrotizing fasciitis requires a multifaceted approach, consisting of surgical source control… 
Review
2015
Review
2015
Abstract Objective: The objective was to conduct a systematic review and network meta-analysis (NMA) of existing treatments for…